CBMT-16. EGFRvIII EXPRESSION CONFERS CHEMOSENSITIVITY BY INCREASING DNA MISMATCH REPAIR PROTEIN EXPRESSION AND REPLICATION STRESS

MGMT promoter methylation is the only accepted biomarker with prognostic role in GBM but its routine implementation is limited partly response to TMZ is heterogeneous, but also due to lack of effective alternative treatment options. Therefore, additional biomarkers are needed to enable better predic...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Neuro Oncol
Main Authors: Struve, Nina, Binder, Zev A, Stead, Lucy F, Brend, Tim, Bagley, Stephen J, Faulkner, Claire, Ott, Leonie, Müller-Goebel, Justus, Weik, Anna-Sophie, Hoffer, Konstantin, Rieckmann, Thorsten, Christin Parplys, Ann, Burmester, Jasmin, Henze, Marvin, Morrissette, Jennifer J D, Schüller, Ulrich, Petersen, Cordula, Rothkamm, Kai, Kurian, Kathreena M, Short, Susan C, Kriegs, Malte
פורמט: Artigo
שפה:Inglês
יצא לאור: Oxford University Press 2019
נושאים:
Cell Biology and Metabolism
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847190/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.138
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים